Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sanjal Desai & Stephen M. Ansell. (2021) Future directions in Hodgkin lymphoma: checkpoint inhibitors and beyond. Leukemia & Lymphoma 62:8, pages 1795-1804.
Read now
Read now
Jorge Vela-Ojeda, Flor Del Carmen Perez-Retiguin, Ana Cristina Olivas-Bejarano, Miriam America Garcia-Ruiz Esparza, Jaime Garcia-Chavez, Abraham Majluf-Cruz, Elba Reyes-Maldonado & Laura Arcelia Montiel-Cervantes. (2021) Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma. Leukemia & Lymphoma 62:4, pages 801-809.
Read now
Read now
Leila Hamdi, Rita Creidy, Sabah Boudjemaa, Houria Hendel-Chavez, Patricia Hugues, Yassine Taoufik, Thierry Leblanc, Aurore Coulomb, Roman Krzysiek, Judith Landman-Parker & Caroline Besson. (2021) Frequent altered distribution of peripheral B-lymphocyte subsets in pediatric and adolescent patients with classical Hodgkin lymphoma. Leukemia & Lymphoma 62:2, pages 300-307.
Read now
Read now
Brady E. Beltran, Christian Aguilar, Pilar Quiñones, Domingo Morales, Julio C. Chavez, Eduardo M. Sotomayor & Jorge J. Castillo. (2016) The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leukemia & Lymphoma 57:1, pages 58-62.
Read now
Read now
Sarmad Said, Haider Alkhateeb, Chad J Cooper, Emmanuel Rodriguez, Remi Trien, German T Hernandez & Hasan S Salameh. (2014) Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review. International Medical Case Reports Journal 7, pages 117-120.
Read now
Read now
Jorge J. Castillo, Domingo Morales, Pilar Quinones, Esther Cotrina, Carlos Desposorio & Brady Beltran. (2010) Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leukemia & Lymphoma 51:10, pages 1822-1828.
Read now
Read now
Articles from other publishers (21)
Rebecca Masel, Megan E. Roche & Ubaldo Martinez-Outschoorn. (2023) Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment. Best Practice & Research Clinical Haematology 36:4, pages 101514.
Crossref
Crossref
Shi-Qi Gao, Bo-Ya Lei, Yue Xu, Zi-Jian Zhang, Xing-Jian Niu, Wen-Hui Zhao, Qing-Yuan Zhang & Shu Zhao. (2023) Identification of leukocyte-lymphocyte ratio as a novel prognostic factor in Peripheral T-cell lymphoma. Holistic Integrative Oncology 2:1.
Crossref
Crossref
Zarema Albakova, Yana Mangasarova & Alexander Sapozhnikov. (2021) Heat Shock Proteins in Lymphoma Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Feodora R. Kosasih, Silvia Vivarelli, Massimo Libra & Benjamin Bonavida. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy
459
475
.
Daniel Ernst, Brent A. Williams, Xing-Hua Wang, Nara Yoon, Kyung-Phil Kim, Jodi Chiu, Zhi Juan Luo, Karin G. Hermans, Joerg Krueger & Armand Keating. (2019) Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1. Blood Cancer Journal 9:2.
Crossref
Crossref
Jodi Chiu, Daniel M. Ernst & Armand Keating. (2018) Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma. Frontiers in Immunology 9.
Crossref
Crossref
Christian Hoffmann, Philipp Schommers, Eva Wolf, Markus Müller, Alexander Schultze, Ivanka Krznaric, Albrecht Stoehr, Timo Wolf, Gerd Fäktenheuer, Bastian Stier, Christoph Wyen & Marcus Hentrich. (2016) CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma. AIDS 30:5, pages 753-760.
Crossref
Crossref
Jing Zhang, Wei Jiang, Wei-Da Wang, Cheng-Cheng Liu, Yan-Ping Hu & Zhong-Jun Xia. (2015) Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma. Asian Pacific Journal of Cancer Prevention 16:11, pages 4515-4520.
Crossref
Crossref
Chuyuan Hong, Yisheng Wei, Jianxin Jiang, Chuxiong Zhao, Guojian Liang, Guoqiang Wang & Hui Yang. (2014) Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer. Asia-Pacific Journal of Clinical Oncology 10:2, pages 168-174.
Crossref
Crossref
Michele Bibas, Maria Paola Trotta, Alessandro Cozzi‐Lepri, Patrizia Lorenzini, Carmela Pinnetti, Giuliano Rizzardini, Gioacchino Angarano, Pietro Caramello, Laura Sighinolfi, Claudio Maria Mastroianni, Giovanni Mazzarello, Antonino Di Caro, Cristina Di Giacomo, Antonella d'Arminio Monforte & Andrea Antinori. (2012) Role of serum free light chains in predicting HIV‐associated non‐Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. American Journal of Hematology 87:8, pages 749-753.
Crossref
Crossref
Jin-Su SongPyeong Gyun ChoeKyoung-Ho SongKyoung Un ParkWan Beom ParkSang Won ParkNam Joong KimMyoung-don OhHong Bin Kim. (2012) Multiple Opportunistic Infections and Primary Central Nervous System Lymphoma in a Patient with Idiopathic CD4+ T-lymphocytopenia. Infection & Chemotherapy 44:1, pages 17.
Crossref
Crossref
Julia BohliusKurt SchmidlinFrançois BouéGerd FätkenheuerMargaret MayAna Maria Caro-MurilloAmanda MocroftFabrice BonnetGary CliffordVassilios PaparizosJose M. MiroNiels ObelMaria Prins, Geneviève Chêne & Matthias Egger. (2011) HIV-1–related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes. Blood 117:23, pages 6100-6108.
Crossref
Crossref
J.J. Huang, W.Q. Jiang, T.Y. Lin, Y. Huang, R.H. Xu, H.Q. Huang & Z.M. Li. (2011) Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Annals of Oncology 22:1, pages 149-155.
Crossref
Crossref
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, Catherine Sebban, Axel Le Cesne, Ian Judson, Olivier Tredan, Jaap Verweij, Pierre Biron, Inthidar Labidi, Jean-Paul Guastalla, Thomas Bachelot, David Perol, Sylvie Chabaud, Pancras C.W. Hogendoorn, Philippe Cassier, Armelle Dufresne & Jean-Yves Blay. (2009) Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas. Cancer Research 69:13, pages 5383-5391.
Crossref
Crossref
Nicolas Penel, Marie Vanseymortier, Marie-Edith Bonneterre, Stéphanie Clisant, Eric Dansin, Yvette Vendel, Régis Beuscart & Jacques Bonneterre. (2007) Prognostic factors among cancer patients with good performance status screened for phase I trials. Investigational New Drugs 26:1, pages 53-58.
Crossref
Crossref
Ulrich A Walker & Klaus Warnatz. (2006) Idiopathic CD4 lymphocytopenia. Current Opinion in Rheumatology 18:4, pages 389-395.
Crossref
Crossref
Fatin Mohammed Omer Al-Sayes & Ali Sawan. (2006) Clinico-Pathological Study of Hodgkin's Disease in King Abdulaziz University Hospital, Jeddah. Journal of Taibah University Medical Sciences 1:1, pages 48-56.
Crossref
Crossref
P Royston, W Sauerbrei & A Ritchie. (2004) Is treatment with interferon-α effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions. British Journal of Cancer 90:4, pages 794-799.
Crossref
Crossref
T Mainou-Fowler, S.J Proctor & P.R.A Taylor. (2004) Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma. Leukemia Research 28:2, pages 159-166.
Crossref
Crossref
R M'kacher, T Girinsky, S Koscielny, J Dossou, D Violot, N Béron-Gaillard, V Ribrag, J Bourhis, A Bernheim, C Parmentier & P Carde. (2003) Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients. International Journal of Radiation Oncology*Biology*Physics 57:2, pages 321-326.
Crossref
Crossref
Paula J. Busse & Charlotte Cunningham-Rundles. (2002) Primary leptomeningeal lymphoma in a patient with concomitant CD4+ lymphocytopenia. Annals of Allergy, Asthma & Immunology 88:3, pages 339-342.
Crossref
Crossref